Skip to main content
SpringerLink
Log in

Better Medicines for 300 Million Children in China

Report on Recent Progress

  • Commentary
  • Published:
Pediatric Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. UNICEF. The state of the world’s children 2009: maternal and newborn health [online]. Available from URL: http://www.unicef.org/sowc09/docs/SOWC09-FullReport-EN.pdf [Accessed 2011 Mar 1]

  2. MDG Monitor. Tracking the millennium development goals: United Nations development programme [online]. Available from URL: www.mdgmonitor.org/country_progress.cfm?c=CHN&cd=156 [Accessed 2011 Feb 6]

  3. International Pediatric Association [online]. Available from URL: www.ipa-world.org [Accessed 2011 Feb 6]

  4. The International Union of Basic and Clinical Pharmacology [online]. Available from URL: www.iuphar.org [Accessed 2011 Feb 6]

  5. MacLeod S, Peterson R, Wang Y, et al. Challenges in international pediatric pharmacology: a milestone meeting in Shanghai. Pediatr Drugs 2007; 9: 215–8

    Article  Google Scholar 

  6. Koren G, Rieder M, MacLeod SM. The global alliance for pediatric pharmacology: the future is here and now. Pediatr Drugs 2009; 11: 4–5

    Article  Google Scholar 

  7. Ministry of Education of the People’s Republic of China: Chinese academic meetings online [online]. Available from URL: http://www.meeting.edu.cn/meeting/meetingNotice/MeetingNotice!detail.action?id=3798 [Accessed 2011 Apr 03]

  8. Commission of the European Communities. Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004 [online]. Available from URL: http://ec.europa.eu/health/files/eudralex/vol-1/reg_2006_1901/reg_2006_1901_en.pdf [Accessed 2011 Mar 18]

  9. European Medicines Agency. Paediatric Committee (PDCO) [online]. Available from URL: http://www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/general/general_content_000265.jsp&murl=menus/about_us/about_us.jsp&mid=WC0b01ac0580028e9d&jsenabled=true [Accessed 2001 Mar 18]

  10. European Medicines Agency. PDCO: committee meeting reports [online]. Available from URL: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/document_listing/document_listing_000192.jsp [Accessed 2011 Mar 18]

  11. National Institutes of Health. Best Pharmaceuticals for Children Act: Title V - Best Pharmaceuticals for Children Amendments of 2007 [online]. Available from URL: http://bpca.nichd.nih.gov/about/background/index.cfm [Accessed 2011 Mar 18]

  12. Rodriguez W, Selen A, Avant D, et al. Improving pediatric dosing through pediatric initiatives: what we have learned. Pediatrics 2008; 121: 530–9

    Article  PubMed  Google Scholar 

  13. Ni SQ, Wang J. Analysis on the problems induced by pediatric unlicensed and off-label drug use [abstract]. 17th National Congress on Pediatric Pharmacy; 2006 Oct 19–22; Nangjin, 83–5

  14. Zuo XP, Gao H. The situation of pediatric drug utilization in China. Chin Pharma Affairs 2002; 16(9): 575

    Google Scholar 

  15. World Health Organization. Essential medicines for children: make medicines child size [online]. Available from URL: www.who.int/childmedicines/en/ [Accessed 2011 March 16]

  16. Li ZP, Wang Y. Drug therapy for children in China. Pediatr Drugs 2009; 11(1): 16–7

    Article  CAS  Google Scholar 

  17. Li ZP. Emphasis should be paid on clinical trials in pediatric patients in China [in Chinese]. J Pediatr Pharm 2009; 15(4): 4–6

    CAS  Google Scholar 

  18. World Health Organization. International Clinical Trials Registry Platform (ICTRP): clinical trials in children [online]. Available from URL: www.who.int/ictrp/child/search/en/ [Accessed 2011 Feb 6]

Download references

Acknowledgements

No sources of funding were used to prepare this commentary. The authors have no conflicts of interest to declare that are directly relevant to the content of this commentary. During the last 4 years, Dr MacLeod has served on several occasions as a consultant or temporary advisor to the WHO Better Medicines for Children Program.

Author information

Authors and Affiliations

  1. Children’s Hospital of Fudan University, Shanghai, China

    Zhiping Li, Yi Wang & Yonghao H. Gui

  2. Peking University First Hospital, Beijing, China

    Li Wang

  3. Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, USA

    Alexander A. Vinks

  4. Centre for International Child Health, University of British Columbia, Rm A4-193, 950 West 28th Avenue, Vancouver, British Columbia, V5Z 4H4, Canada

    Stuart MacLeod

Authors
  1. Zhiping Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Li Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yi Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yonghao H. Gui
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alexander A. Vinks
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Stuart MacLeod
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stuart MacLeod.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, Z., Wang, L., Wang, Y. et al. Better Medicines for 300 Million Children in China. Pediatr-Drugs 13, 137–140 (2011). https://doi.org/10.2165/11591820-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11591820-000000000-00000

Keywords

Search

Navigation